Zhejiang Huahai Pharmaceutical Co Ltd - Company Profile
Powered by
All the data and insights you need on Zhejiang Huahai Pharmaceutical Co Ltd in one report.
- Save hours of research time and resources with
our up-to-date Zhejiang Huahai Pharmaceutical Co Ltd Strategy Report
- Understand Zhejiang Huahai Pharmaceutical Co Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Zhejiang Huahai Pharmaceutical Co Ltd (Huahai Pharmaceuticals) discovers, carries out the research, production and sale of formulations, active pharmaceutical ingredients (APIs) including ace inhibitors, angiotensin II receptor antagonists, anti-AIDS, anti-depressants, antihistamines, antihypertensives, and antipsychotics, and pharmaceutical intermediates. It also carries out the commercial production of captopril, enalapril and lisinopril. The company has two reportable segments, Main Business and Other Business. In Main Business, the company reports the performance of its Raw Material and Intermediaries; Finished Drugs; Technical Services; Import and Export and Others. The company operates through subsidiaries in the US and China and distributes its products to several countries worldwide. Huahai Pharmaceuticals is headquartered in Zhejiang, China.
Zhejiang Huahai Pharmaceutical Co Ltd premium industry data and analytics
Products and Services
Products | Services |
---|---|
Active Pharmaceutical Ingredients | Technology Services |
Pharmaceutical Intermediates | |
Formulations: | |
XYZ | |
XYZ | |
XYZ |
Competitor Comparison
Key Parameters | Zhejiang Huahai Pharmaceutical Co Ltd | Shanghai Pharmaceuticals Holding Co Ltd | China National Accord Medicines Corporation Ltd | Nanjing Pharmaceutical Co Ltd | Jiangsu Hengrui Medicine Co Ltd |
---|---|---|---|---|---|
Headquarters | China | China | China | China | China |
City | Taizhou | Shanghai | Shenzhen | Nanjing | Lianyungang |
State/Province | Zhejiang | Shanghai | Guangdong | Jiangsu | Jiangsu |
No. of Employees | 7,682 | 48,164 | 39,449 | 4,903 | 19,611 |
Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Mei Zhang | Chief Financial Officer; Director - Finance | Senior Management | 2008 | 46 |
Li Hong | Chairman | Executive Board | 2019 | 61 |
Baohua Chen | President; General Manager; Director | Executive Board | 2013 | - |
Zhu Yonghua | Director; Secretary | Executive Board | 2009 | - |
Somfy | Vice President | Senior Management | 2019 | 53 |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer